Posted on 6/10/19
AMSA and Sunovion Partner
MARLBOROUGH, Mass.--(BUSINESS WIRE)--The Advanced Math & Science Academy Charter School (AMSA) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced completion of an inaugural program to help students . . .
Posted on 6/10/19
Thermo Fisher Scientific and Roper Technologies Announce Termination of Gatan Acquisition
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Roper Technologies (NYSE: ROP), a leading diversified technology company, today announced that they . . .
Posted on 6/10/19
Artizan Biosciences Announces Corporate Progress and Financing
NEW HAVEN, Conn., June 10, 2019 (GLOBE NEWSWIRE) -- Artizan Biosciences, Inc., a biotechnology company focused on addressing inflammatory diseases involving the human intestinal microbiota, today . . .
Posted on 6/10/19
T2 Biosystems Reports Granting of Inducement Awards
LEXINGTON, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical . . .
Posted on 6/10/19
Merck to Acquire Tilos Therapeutics
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that it has entered into a definitive agreement to acquire Tilos Therapeutics
Posted on 6/7/19
Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million
Biogen (Nasdaq: BIIB) today announced that it has completed its acquisition of Nightstar Therapeutics (NST; Nasdaq: NITE), a clinical-stage gene therapy company
Posted on 6/7/19
Goldfinch Bio Initiates Phase 1 Clinical Trial of GFB-887 for Kidney Disease
-First-in-Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GFB-887, a Targeted Podocyte-protective Therapeutic for the treatment of Focal Segmental Glomerulosclerosis, Treatment-resistant Minimal Change Disease . . .
Posted on 6/6/19
Thermo Fisher Scientific Acquires HighChem
Thermo Fisher Scientific, the world leader in serving science, today announced that it has completed the acquisition of HighChem, Ltd., a leading developer of mass spectrometry . . .
Posted on 6/6/19
Anthem Acquires Beacon Health Options
INDIANAPOLIS--(BUSINESS WIRE)--Anthem, Inc. (NYSE:ANTM) today announced that the company has entered into a definitive agreement to acquire Beacon Health Options (Beacon), the largest independently held behavioral . . .
Posted on 6/6/19
Provident Healthcare Partners Advises Delray Eye Associates In Its Partnership With EyeCare Services Partners
Delray Eye Associates, a leading comprehensive eye care provider in South Florida, has entered into a strategic partnership with EyeCare Services Partners Management, LLC, the leading . . .
Posted on 6/6/19
XRHealth Announces Partnership with VirZOOM
XRHealth, formerly known as VRHealth, is the leader in extended reality and therapeutic applications, today announced a partnership with VirZOOM, which will transform the power of . . .
Posted on 6/6/19
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on June . . .
Posted on 6/4/19
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, granted 14 newly-hired . . .
Posted on 6/4/19
Precipio Signs Exclusive Manufacturing Agreement for IV-Cell
NEW HAVEN, Conn., June 04, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has entered into an exclusive subcontracting manufacturing . . .
Posted on 6/4/19
Grand Rounds Speeds Up Hiring at Lewiston Location
Grand Rounds, a new kind of healthcare company, today announced that it will significantly grow its Patient Care team in Lewiston, Maine. Grand Rounds, which was . . .
Posted on 6/4/19
Outcome Capital and Partners HealthCare Innovation Collaborate
BOSTON--(BUSINESS WIRE)--Outcome Capital, LLC announced today that it has expanded the Outcome Capital Internship Program to include Partners HealthCare Innovation. The program will provide research fellows . . .
Posted on 6/4/19
WindRose Health Recaps Lykan Bioscience
WindRose Health Investors, LLC, the New York-based healthcare private equity firm, announced the completion of an equity recapitalization of Lykan Bioscience Holdings, LLC. Lykan is a manufacturing . . .
Posted on 6/4/19
Better Buy: Biogen vs. Amgen
Biotech titans Biogen (NASDAQ:BIIB) and Amgen (NASDAQ:AMGN) have both been outstanding growth vehicles for investors over the prior two decades. However, these two biotech stalwarts have . . .
Posted on 6/4/19
Scapa Healthcare Opens New Medical Device Manufacturing Facility in Knoxville, TN
WINDSOR, Conn., June 03, 2019 (GLOBE NEWSWIRE) -- Scapa Healthcare, the trusted strategic partner of choice to the world’s leading companies in advanced wound care, medical . . .
Posted on 6/3/19
Beam Therapeutics and Bio Palette Announce Exclusive License Agreements for Base Editing Technologies
CAMBRIDGE, Mass. & KOBE CITY, Japan--(BUSINESS WIRE)--Beam Therapeutics and Bio Palette today announced an exclusive cross-license agreement around each companies’ base editing intellectual property.Bio Palette, a . . .
Posted on 5/31/19
Better Buy: Berkshire Hathaway vs. IBM
Both Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) and IBM (NYSE:IBM) have been powerful and influential companies for decades. In spite of their many differences in business model and strategy, . . .
Posted on 5/30/19
Hologic Partners with DEXA
ARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that it has signed an agreement with DEXA+ to distribute Hologic’s Horizon® DXA system for body composition measurement.With . . .
Posted on 5/30/19
Magenta Therapeutics: Targeted Conditioning Agents Drive Long-Term Upside
SummaryShares have risen by around 25% since my initial article.I provide a recap of the bullish thesis and recent news.Future catalysts this year include additional data . . .
Posted on 5/29/19
Pillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures
Pillo Health, a Boston-based technology company improving longevity and quality of life for patients managing their health at home, today announced that is has secured $11 . . .
Posted on 5/29/19
Casma Therapeutics Receives Grant from Michael J. Fox Foundation to Support Parkinson’s Drug Development
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced receipt of a Therapeutic Pipeline Program . . .

